By Douglas L. Faulkner, “The Cleantech Conservative” and Gerard J. Ostheimer, PhD Special to the Digest With a nod to the Oscar winning movie of the same name, we want to convey a sense of where the African Bioeconomy is now, where it could be headed, and what is needed for vibrant, enduring growth. The […]
“We’re out of time”. Everyone’s heard the phrase, perhaps most recently in the third act of the motion picture Passengers. But I hadn’t heard it from Charlie Wyman, the legendary NREL researchers, AAAS Fellow, co-founder of Mascoma, and one of the fathers of consolidated bioprocessing, until ABLC. The subject was deployment vs development, whether we […]
With the acquisition of REG and investments in companies such as Raven SR, Chevron has signaled that, as CEO Mike Wirth put it, “we believe the future of energy to be lower carbon. We intend to be a leader today, and in that future.” The Chevron team prepared this company investor update for distribution this […]
In Washington, the Digest released the rankings for the 50 Hottest Companies in the Bioeconomy. Out of more than 2,000 sector companies, the winners are:
The opening session of ABLC features the State of the Bioeconomy presentation. Here are the slides from the presentation by Digest editor & publisher Jim Lane on the evening of March 22nd covering advanced ethanol. renewable diesel, SAF, renewable chemicals, biomaterials, RNG, hydrogen, feedstocks and supply chain, finance and policy.
The company aims to be “ the Most Nimble and Innovative North American Ag Supply Chain Company,” and has operations in the purchase and merchandising of grain, ethanol and plant nutrients (suppling primary nutrients; strong warehouse and farm center network in Eastern Corn Belt). This up to date presentation covers the newer lines of business […]
In Washington, the Biden Administration unveiled bold new goals for biotechnology and biomanufacturing, plus a new report — a delegation of 14 high-ranking officials are headed to ABLC 2023 this week in the capital to provide first reactions and briefings to the bioeconomy industry on the new goals and targets of the Administration. Dr. Arati […]
One of the bioeconomy’s largest public companies has an updated presentation out — all the markets, technologies, sources of revenues, trends, lines of business — launch-stage, growth-stage, maturity and end of life. The BASF team prepared this company investor update for distribution this year.
Novozymes – from the last syllable you can guess at their dominance in the world of creating disruptive yields through enzyme innovation — but did you know of their increasingly strong technology in yeast? What next for this company as it diversifies? All the markets, technologies, sources of revenues, trends, lines of business. The Novozymes […]
